Dynamic Medical Technologies (ROCO:4138) Cyclically Adjusted Revenue per Share: NT$0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4138 Dynamic Medical Technologies Inc ROCO:4138
84 GF Score
Price NT$51.20
GF Value NT$74.27
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Dynamic Medical Technologies Cyclically Adjusted Revenue per Share?

Dynamic Medical Technologies ROCO:4138 +0.39% 84 Cyclically Adjusted Revenue per Share is NT$0.00 as of Mar. 2026. GuruFocus rates ROCO:4138 with a GF Score™ of 84/100 and a GF Value™ of NT$74.27 (Significantly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Dynamic Medical Technologies's adjusted revenue per share for the three months ended in Mar. 2026 was NT$8.515. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$0.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Dynamic Medical Technologies's average Cyclically Adjusted Revenue Growth Rate was 1.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Dynamic Medical Technologies was 4.40% per year. The lowest was 1.50% per year. And the median was 3.25% per year.

As of today (2026-08-05), Dynamic Medical Technologies's current stock price is NT$51.20. Dynamic Medical Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was NT$0.00. Dynamic Medical Technologies's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Dynamic Medical Technologies was 3.21. The lowest was 0.99. And the median was 1.43.


Dynamic Medical Technologies  (ROCO:4138) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Dynamic Medical Technologies was 3.21. The lowest was 0.99. And the median was 1.43.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Dynamic Medical Technologies Cyclically Adjusted Revenue per Share Related Terms


Dynamic Medical Technologies Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Dynamic Medical Technologies's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dynamic Medical Technologies Cyclically Adjusted Revenue per Share Chart

Dynamic Medical Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.67 33.28 35.01 35.55 35.91

Dynamic Medical Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.93 35.92 35.92 35.91 0.00

ROCO:4138 vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Dynamic Medical Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dynamic Medical Technologies Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dynamic Medical Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Dynamic Medical Technologies's Cyclically Adjusted PS Ratio falls into.


ROCO:4138
84GF Score
Dynamic Medical Technologies Inc ROCO:4138
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dynamic Medical Technologies Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dynamic Medical Technologies's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=8.515/330.2130*330.2130
=8.515

Current CPI (Mar. 2026) = 330.2130.

Dynamic Medical Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 7.639 241.018 10.466
201609 6.489 241.428 8.875
201612 6.042 241.432 8.264
201703 6.120 243.801 8.289
201706 6.571 244.955 8.858
201709 6.144 246.819 8.220
201712 6.220 246.524 8.332
201803 7.458 249.554 9.869
201806 7.877 251.989 10.322
201809 7.163 252.439 9.370
201812 6.591 251.233 8.663
201903 7.420 254.202 9.639
201906 7.748 256.143 9.989
201909 6.778 256.759 8.717
201912 7.501 256.974 9.639
202003 6.625 258.115 8.476
202006 5.729 257.797 7.338
202009 6.155 260.280 7.809
202012 6.641 260.474 8.419
202103 7.170 264.877 8.939
202106 5.462 271.696 6.638
202109 5.537 274.310 6.665
202112 7.465 278.802 8.842
202203 7.713 287.504 8.859
202206 6.983 296.311 7.782
202209 7.834 296.808 8.716
202212 9.721 296.797 10.815
202303 9.811 301.836 10.733
202306 10.310 305.109 11.158
202309 9.477 307.789 10.167
202312 10.204 306.746 10.985
202403 10.071 312.332 10.648
202406 9.942 314.175 10.450
202409 8.884 315.301 9.304
202412 10.327 315.605 10.805
202503 8.794 319.799 9.080
202506 8.157 322.561 8.351
202509 8.463 324.800 8.604
202512 9.209 324.054 9.384
202603 8.515 330.213 8.515

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$0.00 mean?
Dynamic Medical Technologies (ROCO:4138) has a Cyclically Adjusted Revenue per Share of NT$0.00 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dynamic Medical Technologies and its competitors.
Is Dynamic Medical Technologies' Cyclically Adjusted Revenue per Share too high?
Dynamic Medical Technologies' current Cyclically Adjusted Revenue per Share is NT$0.00. Overall, Dynamic Medical Technologies has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynamic Medical Technologies' Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Dynamic Medical Technologies' Cyclically Adjusted Revenue per Share of NT$0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dynamic Medical Technologies and its competitors. Dynamic Medical Technologies's current Cyclically Adjusted Revenue per Share is NT$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamic Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, Dynamic Medical Technologies (ROCO:4138) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$74.27, compared to a current price of NT$51.20 — trading 31.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$0.00. Dynamic Medical Technologies' overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Dynamic Medical Technologies (ROCO:4138), the current Cyclically Adjusted Revenue per Share is NT$0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dynamic Medical Technologies (ROCO:4138) Overvalued in 2026?

Based on GuruFocus' analysis, Dynamic Medical Technologies stock appears to be undervalued. The current stock price of NT$51.20 is trading 31.1% below its estimated GF Value™ of NT$74.27. GuruFocus considers Dynamic Medical Technologies to be Significantly Undervalued.

Key valuation signals for ROCO:4138:

  • Cyclically Adjusted Revenue per Share: NT$0.00
  • GF Value™: NT$74.27 vs. price of NT$51.20 (31.1% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dynamic Medical Technologies Business Description

Address No. 880, Zhongzheng Road, 14th Floor, Zhonghe District, New Taipei City, TWN, 23586
Dynamic Medical Technologies Inc is engaged in the sales, maintenance, and integrated marketing of aesthetic lasers and light-based equipment. The company's product line includes aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The reportable segments after the adjustment are the Medical equipment trading segment and the Beauty channel segment. The Medical equipment trading segment includes selling, leasing, and repairing medical aesthetic equipment and selling the medical aesthetic consumables and cosmetic products. The Beauty channel segment generates revenues from the sale of lifestyle beauty products and treatments at physical store, as well as the sale of medical aesthetic products.
84GF Score

Get the complete analysis for ROCO:4138

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$51.20
Price
NT$74.27
GF Value